Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,382,313
-
Total 13F shares
-
35,724,879
-
Share change
-
-4,382,817
-
Total reported value
-
$51,820,655
-
Price per share
-
$1.45
-
Number of holders
-
79
-
Value change
-
-$5,881,536
-
Number of buys
-
46
-
Number of sells
-
49
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q2 2025
As of 30 Jun 2025,
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,724,879 shares.
The largest 10 holders included
Lynx1 Capital Management LP, BVF INC/IL, BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, Propel Bio Management, LLC, Deer Management Co. LLC, Alphabet Inc., Simplify Asset Management Inc., and Aberdeen Group plc.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.